Graphical abstract from Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes, by Bailey, Flatt, and Conlon, licensed under CC BY 4.0 Subscribe by email to follow the accumulating evidence and observations that shape our view of health, obesity, and policy.
After the washout, start semaglutide at a low dosetypically 0.25 mg weekly if you were on a low tirzepatide dose, or 0.5 mg weekly if you were on a higher tirzepatide dose
Another way to verify coverage is by using the Novo Nordisk costs and coverage tool
10.1111/j.1365-4632.2011.05305.x 169 MonteiroR.KishoreB.BhatR.DandekeriS.MartisJ.HundiG
Researchers ran parallel trials in people with and without type 2 diabetes at sites across multiple countries, comparing the higher dose with the current standard dose and with placebo to understand its full impact